Every agreement. Every therapy.

Pharmaceutical agreements govern the clinical, manufacturing, commercial, and regulatory relationships behind every therapy. Make every agreement perform.

Key Benefits

Use Cases

How We Deliver

Customer Stories

Resources

Icertis in Action

Strengthen clinical execution

Manage Clinical Trial Agreements (CTAs), investigator payments, and Clinical Research Organization (CRO) obligations to support consistent trial execution.

Build supply chain resilience

Connect CDMO agreements, API sourcing, and Good Manufacturing Practice obligations to strengthen supply continuity.

Accelerate market access

Connect Pharmacy Benefit Manager (PBM) rebate agreements, formulary terms, and government pricing provisions to accelerate market access.

Regulatory confidence, built in

Track FDA commitments, European Medicines Agency (EMA) submissions, and transparency reporting obligations across global markets.

Clinical development

Centralize CTAs and research contracts to strengthen execution across every phase of clinical development.

Track investigator payments, study milestones, and protocol amendments across multicenter clinical research programs.
Manage CRO agreements, site obligations, and sponsor commitments across global clinical development programs.
Surface protocol amendments, milestone commitments, and study obligations before they affect study execution.

Manufacturing & supply

Manage manufacturing, sourcing, and quality agreements to strengthen supply continuity and operational resilience.

Track CDMO agreements, manufacturing obligations, and quality commitments across global production partners.
Monitor API sourcing commitments, supply obligations, and contract amendments before production schedules are affected.
Identify quality commitments, supply obligations, and contract changes before they affect manufacturing continuity.

Market access & pricing

Manage market access, pricing, and rebate agreements to accelerate commercialization and revenue realization.

Track PBM rebate agreements, formulary placement terms, and government pricing provisions across commercial channels.
Surface pricing amendments, rebate obligations, and renewal milestones before they affect formulary access and commercial performance.
Identify pricing risks, rebate variances, and agreement changes before they affect revenue realization.

Compliance & audit readiness

Manage regulatory and quality commitments across products, markets, and global jurisdictions.

Map FDA, European Medicines Agency (EMA), and transparency reporting requirements to specific contract obligations.
Respond to regulatory changes with visibility into every affected clinical, manufacturing, and commercial agreement.
Maintain audit-ready documentation across global regulatory requirements without manual tracking.